159 related articles for article (PubMed ID: 8631036)
1. Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins.
Frankel AE; FitzGerald D; Siegall C; Press OW
Cancer Res; 1996 Feb; 56(4):926-32. PubMed ID: 8631036
[No Abstract] [Full Text] [Related]
2. Immunotoxins in the therapy of cancer: from bench to clinic.
Ghetie V; Vitetta E
Pharmacol Ther; 1994 Sep; 63(3):209-34. PubMed ID: 7831391
[TBL] [Abstract][Full Text] [Related]
3. Immunotoxin therapy of lymphoma.
Grossbard ML; Nadler LM
Cancer Treat Res; 1993; 68():111-31. PubMed ID: 8105846
[No Abstract] [Full Text] [Related]
4. Immunotoxin therapy of hematological malignancies.
Pasqualucci L; Flenghi L; Terenzi A; Bolognesi A; Stirpe F; Bigerna B; Falini B
Haematologica; 1995; 80(6):546-56. PubMed ID: 8647523
[No Abstract] [Full Text] [Related]
5. Immunotoxins for treatment of leukemia and lymphoma.
Uckun FM; Reaman GH
Leuk Lymphoma; 1995 Jul; 18(3-4):195-201. PubMed ID: 8535182
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic use of immunotoxins.
Cobb PW; LeMaistre CF
Semin Hematol; 1992 Jul; 29(3 Suppl 2):6-13. PubMed ID: 1509295
[TBL] [Abstract][Full Text] [Related]
7. Immunotoxin therapy of malignant melanoma.
Spitler LE
Med Oncol Tumor Pharmacother; 1986; 3(3-4):147-52. PubMed ID: 3543527
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis.
Reiter Y; Pastan I
Trends Biotechnol; 1998 Dec; 16(12):513-20. PubMed ID: 9881483
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxins in the therapy of leukemias and lymphomas.
Hertler AA; Frankel AE
Cancer Invest; 1991; 9(2):211-9. PubMed ID: 1863876
[No Abstract] [Full Text] [Related]
10. Immunotoxin therapy of lymphoid neoplasms.
Grossbard ML; Nadler LM
Semin Hematol; 1994 Jan; 31(1):88-97. PubMed ID: 8122137
[No Abstract] [Full Text] [Related]
11. [Immunotoxin: from the idea of "magic bullets" to clinical applications].
Engert A; Thorpe P
Med Klin (Munich); 1990 Sep; 85(9):555-60. PubMed ID: 2233614
[No Abstract] [Full Text] [Related]
12. The emerging role of ricin A-chain immunotoxins in leukemia and lymphoma.
Engert A; Sausville EA; Vitetta E
Curr Top Microbiol Immunol; 1998; 234():13-33. PubMed ID: 9670610
[TBL] [Abstract][Full Text] [Related]
13. The current status of immunotoxins: an overview of experimental and clinical studies as presented at the Third International Symposium on Immunotoxins.
Uckun FM; Frankel A
Leukemia; 1993 Feb; 7(2):341-8. PubMed ID: 8093912
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxin therapy: assessment by animal models.
Griffin TW; Morgan AC; Blythman HE
Cancer Treat Res; 1988; 37():433-55. PubMed ID: 2908638
[No Abstract] [Full Text] [Related]
15. Immunotoxins in cancer therapy: Review and update.
Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
[TBL] [Abstract][Full Text] [Related]
17. Immunotoxins and toxin constructs in the treatment of leukemia and lymphoma.
Rosenblum M
Adv Pharmacol; 2004; 51():209-28. PubMed ID: 15464911
[No Abstract] [Full Text] [Related]
18. Serotherapy of cancer.
Harris DT; Mastrangelo MJ
Semin Oncol; 1989 Jun; 16(3):180-98. PubMed ID: 2658082
[No Abstract] [Full Text] [Related]
19. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
Zovickian J; Johnson VG; Youle RJ
J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-based therapies of leukemia and lymphoma.
Grossbard ML; Press OW; Appelbaum FR; Bernstein ID; Nadler LM
Blood; 1992 Aug; 80(4):863-78. PubMed ID: 1498329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
